Month: August 2020

Schlieren/Switzerland, 13 August 2020The news release can be downloaded from the following link:AttachmentRelease

Press ReleaseRecruitment on track with 164 patients already treatedGosselies, Belgium, 13 August 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing high unmet medical needs in orthopedics and bone diseases, today announces it has been granted EUR 1.0 million in non-dilutive funding from the Directorate-General for Economy, Employment and Research of the Walloon Region, Belgium. This funding will provide further financial support to Bone Therapeutics, in addition to recent financing, to advance its current pivotal phase III clinical study with the enriched protein solution, JTA-004.The JTA-004 phase III study is a controlled, randomized, double-blind trial. It is evaluating the potential of a single, intra-articular injection of JTA-004 to reduce osteoarthritic pain in the knee...

Communiqué de presseLe recrutement des patients se poursuit conformément au calendrier initial avec 164 patients traités à ce jourGosselies, Belgique, le 13 août 2020, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires et biologiques innovantes répondant à d’importants besoins médicaux non satisfaits dans les domaines de l’orthopédie et des maladies osseuses, annonce aujourd’hui que la Direction Générale de l’Économie, l’Emploi et la Recherche de la région Wallonne, en Belgique, lui a octroyé un financement de 1,0 M€ en fonds non dilutifs. Ce financement vient renforcer la trésorerie de Bone Therapeutics et soutiendra le développement de son essai clinique pivot de phase III évaluant actuellement JTA-004, une solution de...

Norwegian Finans Holding (the NFH Group) reported comprehensive income in the second quarter of 2020 NOK 582.1 million after tax, compared with NOK 368.0 million in the first quarter. The increase is mainly caused by lower provision for loan losses, gains on securities and lower digital marketing costs.Return on equity was 24.5%, compared with 16.2% in the first quarter and the return on assets was 3.9%, compared with 2.5% in the first quarter.Gross loans to customers decreased NOK 2 292 million compared with an increase NOK 2 860 million in the previous quarter and totaled NOK 44 723 million. Currency adjusted gross loan growth was NOK -1 276 million compared with NOK -733.3 million in the previous quarter. Broken down by product the currency adjusted loan growth for instalment loans was NOK -653.0 million compared with NOK 375.4 million...

Trondheim, 13 May 2020: NORBIT, a global provider of tailored technology to carefully selected niches, today reported revenues for the second quarter of 2020 of NOK 155.2 million, compared to NOK 169.7 million for the corresponding period of 2019. For the first half of 2020, the company had revenues of NOK 306.7 million, compared to NOK 327.3 million for the same period of 2019.“I am pleased to see that we manage both to increase our revenues and improve our margins from the previous quarter, despite the challenges we experience in most aspects of our business following the pandemic. We see signs of improvement in several markets and regions, and the positive market response received on the recently launched WINGHEAD sonar confirms our strategy to invest in broadening our product portfolio,” says Per Jørgen Weisethaunet, CEO of NORBIT.NORBIT...

Trondheim, 13. mai 2020: NORBIT, en global leverandør av skreddersydd teknologi til utvalgte nisjer, rapporterte i dag inntekter for andre kvartal 2020 på 155,2 millioner kroner, sammenlignet med 169,7 millioner kroner i andre kvartal i fjor. Selskapets inntekter for første halvår endte på 306,7 millioner kroner, mot 327,3 millioner kroner i samme periode for 2019.«Vi er fornøyde med at vi både øker omsetningen og forbedrer marginene våre fra første kvartal i år til tross for utfordringene vi opplever i virksomheten på grunn av pandemien. Vi ser tegn til forbedring i flere markeder og regioner, og den positive responsen vi har fått på den nylig lanserte WINGHEAD sonaren viser at strategien om å investere i å utvide produktporteføljen er riktig for oss,» sier Per Jørgen Weisethaunet, administrerende direktør i NORBIT.NORBIT leverte en...

Allschwil, Switzerland – August 13, 2020Idorsia Ltd (SIX: IDIA) today announced that the positive results from the first pivotal Phase 3 study investigating 25 and 50 mg doses of its dual orexin receptor antagonist, daridorexant, in adult and elderly patients with insomnia, are to be presented at SLEEP 2020. Due to the COVID-19 pandemic, the Associated Professional Sleep Societies (APSS) is turning SLEEP 2020, the world’s largest meeting devoted entirely to clinical sleep medicine, and sleep and circadian research, into a virtual meeting from August 27 – 30, 2020. The meeting has live-streamed content as well as on-demand recorded sessions to view.The abstract entitled “A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Polysomnography Study to Assess Efficacy and Safety of Daridorexant in Adult and Elderly Insomnia...

Allschwil, Switzerland – August 13, 2020Idorsia Ltd (SIX: IDIA) today announced that the positive results from the first pivotal Phase 3 study investigating 25 and 50 mg doses of its dual orexin receptor antagonist, daridorexant, in adult and elderly patients with insomnia, are to be presented at SLEEP 2020. Due to the COVID-19 pandemic, the Associated Professional Sleep Societies (APSS) is turning SLEEP 2020, the world’s largest meeting devoted entirely to clinical sleep medicine, and sleep and circadian research, into a virtual meeting from August 27 – 30, 2020. The meeting has live-streamed content as well as on-demand recorded sessions to view.The abstract entitled “A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Polysomnography Study to Assess Efficacy and Safety of Daridorexant in Adult and Elderly Insomnia...

Marimekko Corporation, Press release, 13 August 2020 at 7:50 a.m.Due to the coronavirus pandemic, the global fashion and specialty retail sector is facing the worst crisis in decades. The pandemic has expedited the transformation of consumers’ purchasing behavior and intensified structural changes in the sector, such as digitalization. It has accelerated the shift to digital sales channels among customers — including new customer groups — and this will also influence Marimekko’s distribution channel choices in the future. At the same time, the coronavirus crisis has taken uncertainty over the global economy to a completely new level, and consumers’ increased price sensitivity as a result of recession and growth in surplus inventories due to the pandemic create pressure for profitability for the fashion sector.Marimekko’s operating environment...

Marimekko Oyj, Lehdistötiedote 13.8.2020 klo 7.50